Tagrisso, un medicamento dirigido, podría ser un avance contra el cáncer de pulmón
LUNES, 6 de febrero de 2023 (HealthDay News) — El mejor tratamiento para una forma de cáncer de pulmón de origen genético sigue mostrando unos beneficios duraderos, según una nueva actualización de un ensayo clínico.Tagrisso (osimertinib) casi duplic…
Learn MoreLung Cancer Screening Based on Personal Risk Is Cost-Effective
TUESDAY, Feb. 7, 2023 (HealthDay News) — Lung cancer screening strategies based on personal risk are more cost effective than the 2021 U.S. Preventive Services Task Force (USPSTF) recommendations, according to a study published online Feb. 7 in the A…
Learn MoreDefensive Information Processing Is Barrier to CRC Screening Uptake
TUESDAY, Feb. 7, 2023 (HealthDay News) — Defensive information processing (DIP) is a barrier to colorectal cancer screening uptake, according to a study published online Feb. 6 in Cancer.Nicholas Clarke, Ph.D., from Dublin City University in Ireland,…
Learn MoreHealthy Lifestyle Cuts Odds for Long COVID in Half
TUESDAY, Feb. 7, 2023 (HealthDay News) — People who get COVID-19 are at risk for long-term health consequences, but a healthy lifestyle may protect against long COVID, a new study suggests.Women who maintained six healthy habits — a healthy weight, …
Learn MoreAdvent of Electric Cars Is Already Improving Health
TUESDAY, Feb. 7, 2023 (HealthDay News) — Electric cars are still in the minority on America’s roads, yet researchers are already seeing health benefits from reduced tailpipe pollution. In a new California study, neighborhoods with the most all-electr…
Learn MoreObamacare ayudó a las mujeres en algunos estados del Sur a recibir mejor atención para el cáncer de mama
VIERNES, 3 de febrero de 2023 (HealthDay News) — La Ley del Cuidado de Salud a Bajo Precio (Affordable Care Act, ACA) expandió Medicaid, lo que aumentó las probabilidades de que una mujer sea diagnosticada más temprano, en lugar de en una etapa avanz…
Learn MoreTargeted Drug Tagrisso Could Be Advance Against Lung Cancer
MONDAY, Feb. 6, 2023 (HealthDay News) — The best treatment for a genetically driven form of lung cancer continues to show lasting benefits, a new clinical trial update shows.Tagrisso (osimertinib) nearly doubles disease-free survival in earlier-stage…
Learn MorePandemic-Linked Decline in Cancer Screening Persisted Into 2022
MONDAY, Feb. 6, 2023 (HealthDay News) — The decrease in cancer screening seen during the early stage of the COVID-19 pandemic persisted into 2022, according to a study published online Feb. 3 in JAMA Network Open.Christopher Doan, from the University…
Learn MoreUltra-Processed Food Intake Linked to Cancer Burden, Mortality
MONDAY, Feb. 6, 2023 (HealthDay News) — Higher consumption of ultra-processed food (UPF) is associated with increased cancer burden and cancer-related mortality, especially ovarian cancer, according to a study published online Jan. 31 in eClinicalMed…
Learn MoreOutcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
MONDAY, Feb. 6, 2023 (HealthDay News) — Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in the morning, according to a st…
Learn More